Source link : https://www.newshealth.biz/health-news/lebrikizumab-wins-fda-approval-for-eczema/
The FDA approved lebrikizumab (Ebglyss) for treating atopic dermatitis in adults and children ages 12 years and up, drugmaker Eli Lilly announced on Friday. Approval of the injectable interleukin (IL)-13 inhibitor stipulates use with or without topical corticosteroids for patients with moderate-to-severe cases of the chronic skin condition that is not well controlled despite use […]
Author : News Health
Publish date : 2024-09-13 21:43:06
Copyright for syndicated content belongs to the linked Source.